Profiel
Jenna Daly is currently Vice President-Clinical Operations at Janux Therapeutics, Inc. Formerly, Ms. Daly was Senior Director-Project Management at SynteractHCR Corp.
from 2020 to 2021 and Manager-Clinical Operations at CancerVax Corp.
from 2004 to 2006.
Education includes an undergraduate degree from the University of California, Los Angeles and an MBA from San Diego State University.
Actieve functies van Jenna Daly
| Bedrijven | Functie | Begin |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Jenna Daly
| Bedrijven | Functie | Einde |
|---|---|---|
SynteractHCR Corp.
SynteractHCR Corp. Pharmaceuticals: MajorHealth Technology Engaged in outsourced pharmaceutical services | Corporate Officer/Principal | 01-05-2021 |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Hoofd Techniek/Wetenschap/O&O | 01-02-2006 |
Opleiding van Jenna Daly
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SynteractHCR Corp.
SynteractHCR Corp. Pharmaceuticals: MajorHealth Technology Engaged in outsourced pharmaceutical services | Health Technology |
Janux Therapeutics, Inc.
Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
















